Exhibit D
JOINT FILING STATEMENT
I, the undersigned, hereby express my agreement that the attached Schedule 13D (and any amendments thereto) relating to the Common Stock of Celator Pharmaceuticals, Inc. is filed on behalf of each of the undersigned.
Dated: May 9, 2013
VALENCE LIFE SCIENCES GP II, LLC |
| CDK ASSOCIATES LLC | ||
|
|
| ||
|
| By: | Caxton Corporation, | |
By: | /s/ Eric W. Roberts |
|
| its Manager |
| Name: Eric W. Roberts |
|
| |
| Title: Managing Member |
|
| |
|
| By: | /s/ Heath Weisberg | |
|
|
| Name: Heath Weisberg | |
|
|
| Title: Chief Compliance Officer | |
|
|
| ||
|
|
| ||
VALENCE ADVANTAGE LIFE SCIENCES FUND II, L.P. |
| CAXTON CORPORATION | ||
|
|
| ||
By: | Valence Life Sciences GP II, LLC, |
|
| |
| its General Partner |
|
| |
|
| By: | /s/ Heath Weisberg | |
|
|
| Name: Heath Weisberg | |
By: | /s/ Eric W. Roberts |
|
| Title: Chief Compliance Officer |
| Name: Eric W. Roberts |
|
| |
| Title: Managing Member |
|
| |
|
|
| ||
|
|
| ||
VALENCE ADVANTAGE LIFE SCIENCES SIDE FUND II, L.P. |
| BRUCE KOVNER | ||
|
|
| ||
By: | Valence Life Sciences GP II, LLC, |
|
| |
| its General Partner |
|
| |
|
| /s/ Heath Weisberg | ||
|
|
| Name: Heath Weisberg | |
By: | /s/ Eric W. Roberts |
|
| Title: Attorney-in-Fact |
| Name: Eric W. Roberts |
|
| |
| Title: Managing Member |
|
| |
